| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |